These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32022744)

  • 21. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.
    Sterling TR; Njie G; Zenner D; Cohn DL; Reves R; Ahmed A; Menzies D; Horsburgh CR; Crane CM; Burgos M; LoBue P; Winston CA; Belknap R
    MMWR Recomm Rep; 2020 Feb; 69(1):1-11. PubMed ID: 32053584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.
    Huang YW; Yang SF; Yeh YP; Tsao TC; Tsao SM
    Medicine (Baltimore); 2016 Aug; 95(34):e4126. PubMed ID: 27559940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in diagnosis and treatment of latent tuberculosis infection.
    Chapman HJ; Lauzardo M
    J Am Board Fam Med; 2014; 27(5):704-12. PubMed ID: 25201941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
    Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
    Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of latent tuberculosis infection: An update.
    Lobue P; Menzies D
    Respirology; 2010 May; 15(4):603-22. PubMed ID: 20409026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis: an overview.
    Cruz-Knight W; Blake-Gumbs L
    Prim Care; 2013 Sep; 40(3):743-56. PubMed ID: 23958367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis.
    Njie GJ; Morris SB; Woodruff RY; Moro RN; Vernon AA; Borisov AS
    Am J Prev Med; 2018 Aug; 55(2):244-252. PubMed ID: 29910114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uncloaking an ancient adversary: Can pathogen biomarker elicitors play a role in confirming extrapulmonary TB and latent TB infection?
    Porter BW; Venkatappa TK
    Tuberculosis (Edinb); 2018 Dec; 113():30-37. PubMed ID: 30514511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up.
    Harries AD; Kumar AMV; Satyanarayana S; Takarinda KC; Timire C; Dlodlo RA
    Expert Rev Respir Med; 2020 Feb; 14(2):195-208. PubMed ID: 31760848
    [No Abstract]   [Full Text] [Related]  

  • 30. Tuberculosis.
    Kelly AM
    Nurs Clin North Am; 2019 Jun; 54(2):193-205. PubMed ID: 31027661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection.
    Pease C; Hutton B; Yazdi F; Wolfe D; Hamel C; Barbeau P; Skidmore B; Alvarez GG
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):557-566. PubMed ID: 29573031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda.
    Ferguson O; Jo Y; Pennington J; Johnson K; Chaisson RE; Churchyard G; Dowdy D
    J Int AIDS Soc; 2020 Oct; 23(10):e25623. PubMed ID: 33073520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
    Villarino ME; Scott NA; Weis SE; Weiner M; Conde MB; Jones B; Nachman S; Oliveira R; Moro RN; Shang N; Goldberg SV; Sterling TR; ;
    JAMA Pediatr; 2015 Mar; 169(3):247-55. PubMed ID: 25580725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen.
    Hedges KNC; Borisov AS; Saukkonen JJ; Scott NA; Hecker EJ; Bozeman L; Dukes Hamilton C; Kerrigan A; Bessler P; Moreno-Martinez A; Arevalo B; Goldberg SV
    Clin Trials; 2020 Feb; 17(1):39-51. PubMed ID: 31690107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latent Mycobacterium tuberculosis infection.
    Getahun H; Matteelli A; Chaisson RE; Raviglione M
    N Engl J Med; 2015 May; 372(22):2127-35. PubMed ID: 26017823
    [No Abstract]   [Full Text] [Related]  

  • 36. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
    Schechter M; Zajdenverg R; Falco G; Barnes GL; Faulhaber JC; Coberly JS; Moore RD; Chaisson RE
    Am J Respir Crit Care Med; 2006 Apr; 173(8):922-6. PubMed ID: 16474028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
    Chen YM; Liao TL; Chen HH; Chen DY
    Ann Rheum Dis; 2018 Nov; 77(11):1688-1689. PubMed ID: 29674320
    [No Abstract]   [Full Text] [Related]  

  • 38. Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.
    Moro RN; Scott NA; Vernon A; Tepper NK; Goldberg SV; Schwartzman K; Leung CC; Schluger NW; Belknap RW; Chaisson RE; Narita M; Machado ES; Lopez M; Sanchez J; Villarino ME; Sterling TR
    Ann Am Thorac Soc; 2018 May; 15(5):570-580. PubMed ID: 29393655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches in the diagnosis and treatment of latent tuberculosis infection.
    Ahmad S
    Respir Res; 2010 Dec; 11(1):169. PubMed ID: 21126375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
    Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R
    Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.